DOMUS MEDICUS ApS
APSDissolvedAdvertising protectionCVR 29184526Vendersgade 26D, 7000 FredericiaOther financial service activities, except insurance and pension funding n.e.c.· NACE 6499Est. 2005 · 20 years old— employees
Loading company…
Overview
DOMUS MEDICUS ApS is a Danish APS based in Fredericia, operating in the Other financial service activities, except insurance and pension funding n.e.c. sector. Incorporated in 2005, the company reported a gross profit of -DKK 23.8k in its latest annual filing.
Gross profit 2023
-23.8K DKK
+72% vs 2022
EBITDA margin (of gross profit)
100.0 %
−72% vs 2022
Net profit 2023
-22.1K DKK
+2% vs 2022
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
97.6 %
StrongAmong the 40% highest rated companies in the industry
20192023
Liquidity ratioCurrent assets ÷ Short-term debt
40.9×
StrongAmong the 30% highest rated companies in the industry
20192023
Return on assets (ROA)Net profit ÷ Total assets × 100
-3.1 %
WeakAmong the 30% lowest rated companies in the industry
20192023
EBITDA — year on year
DKK thousandsKey figures
Annual report 2023| Gross profit | -23.8K DKK | +72% |
| EBITDA | -23.8K DKK | -72% |
| Net profit | -22.1K DKK | +2% |
| Total assets | 715.3K DKK | -34% |
| Equity | 697.8K DKK | -35% |
| Employees | — | — |
Company information
Legal name
DOMUS MEDICUS ApS
CVR number
29184526
Legal form
Anpartsselskab
Founded
25 November 2005 · 20 years
Share capital
DKK 125,000
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Contact
Address
Vendersgade 26D, 7000 Fredericia
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2023), DOMUS MEDICUS ApS reported a gross profit of -DKK 23.8k. The figures on this page draw on 5 annual filings covering 2019 to 2023. The bottom line showed a net loss of DKK 22.1k.
At the end of 2023, equity financed 97.6% of the balance sheet, and current assets covered short-term debt 40.9 times.
Financials
Gross profit
DKK thousandsEBITDA
DKK thousandsIncome statement
DKK thousands| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Gross profit | -24 | -14 | 214 | 327 | 342 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -24 | -14 | 844 | 327 | 342 |
| Depreciation & amort. | -0 | -0 | 315 | -4 | -16 |
| EBIT | -24 | -14 | 529 | 324 | 326 |
| Net financials | 2 | -9 | -55 | -34 | -39 |
| Profit before tax | -22 | -23 | 474 | 289 | 287 |
| Tax | -0 | -0 | 39 | 64 | 68 |
| Net profit | -22 | -23 | 435 | 226 | 220 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
DKK thousands| Item | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total assets | 715 | 1,084 | 1,472 | 3,244 | 3,233 |
| Equity | 698 | 1,073 | 1,439 | 1,344 | 1,118 |
| Long-term debt | 0 | 0 | 0 | 1,428 | 1,616 |
| Short-term debt | 18 | 11 | 33 | 472 | 498 |
| Total debt | 18 | 11 | 33 | 1,900 | 2,115 |
Financial ratios
5-year trendEBITDA margin (of gross profit)
<−999 %
20192023
Equity ratio
97.6 %
StrongAmong the 40% highest rated companies in the industry
20192023
Return on equity
-3.2 %
WeakAmong the 30% lowest rated companies in the industry
20192023
Net profit margin (of gross profit)
<−999 %
20192023
Asset turnover (of gross profit)
-0.03×
20192023
Debt / equity
0.03×
AverageAround the average of companies in the same industry
20192023
Sector performance
22 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on equity (ROE)Weak
Among the 30% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Weak
Among the 30% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Weak
Among the 30% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very weak
Among the 20% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioStrong
Among the 30% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioStrong
Among the 30% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery strong
Among the 10% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityWeak
Among the 30% lowest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery strong
Among the 10% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioVery strong
Among the 20% highest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioStrong
Among the 40% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioStrong
Among the 40% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityAverage
Around the average of companies in the same industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityAverage
Around the average of companies in the same industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery weak
Among the 20% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 20% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 10% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtStrong
Among the 30% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginWeak
Among the 40% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Equity to contributed capitalWeak
Among the 40% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery weak
Among the 10% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtVery weak
Among the 20% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Asset turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|
Former (4)
CE Management | Management | 2007 – 2025 |
OH Management | Management | 2005 – 2019 |
HB Management | Management | 2017 – 2025 |
AK Management | Management | 2019 – 2025 |
Board of directors
Non-executive oversightNo data on file.
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Individual | 33.33–49.99% | 33.33–49.99% | 2017 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2017 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2017 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
HOFFMANN, FREDERICIA ApS
DOMUS MEDICUS ApS Board network connections
Board members of DOMUS MEDICUS ApS also hold positions in 10 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olaf Hoffmann | Management | 4 companies |
| Christina Ellegaard Tjørnehøj Kraaer | Management | 2 companies |
| Heidi Bruun | Management | 2 companies |
| Ann Kristine Ulsrod Madsen | Management | 2 companies |
Frequently asked questions
What is the CVR number of DOMUS MEDICUS ApS?
DOMUS MEDICUS ApS is registered with CVR / Virk under CVR 29184526.
What is the gross profit of DOMUS MEDICUS ApS?
DOMUS MEDICUS ApS reported a gross profit of -DKK 23.8k in 2023.
Where is DOMUS MEDICUS ApS headquartered?
DOMUS MEDICUS ApS's registered address is Vendersgade 26D.